AJANTPHARM.NS Cash Flow
Ajanta Pharmaceuticals Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:33
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹791.78 Cr. | ₹785.07 Cr. | ₹1,157.23 Cr. | ₹529.19 Cr. | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-559.60 Cr. | ₹65.39 Cr. | ₹-376.52 Cr. | ₹-428.92 Cr. | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹-107.87 Cr. | ₹-1,051.06 Cr. | ₹-733.41 Cr. | ₹-167.92 Cr. | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹-0.84 Cr. | ₹0.26 Cr. | ₹-1.67 Cr. | ₹-4.21 Cr. | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹123.47 Cr. | ₹-200.34 Cr. | ₹45.63 Cr. | ₹-71.86 Cr. | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹206.36 Cr. | ₹329.83 Cr. | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from AJANTPHARM.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).